Join the 'Methocarbamol' group to help and get support from people like you.

Methocarbamol Blog

Medication Errors Occur Every 8 Minutes in U.S. Children

Posted 10 days ago by Drugs.com

MONDAY, Oct. 20, 2014 – A child receives the wrong medication or the wrong dosage every eight minutes in the United States, according to a recent study. Nearly 700,000 children under 6 years old experienced an out-of-hospital medication error between 2002 and 2012. Out of those episodes, one out of four children was under a year old. As the age of children decreased, the likelihood of an error increased, the study found. Though 94 percent of the mistakes didn't require medical treatment, the errors led to 25 deaths and about 1,900 critical care admissions, according to the study. "Even the most conscientious parents make errors," said lead author Dr. Huiyun Xiang, director of the Center for Pediatric Trauma Research at Nationwide Children's Hospital in Columbus, Ohio. That conscientiousness may even lead to one of the most common errors: Just over a quarter of these mistakes involved a ... Read more

Related support groups: Xanax, Klonopin, Seroquel, Clonazepam, Valium, Ativan, Abilify, Soma, Alprazolam, Lorazepam, Flexeril, Benadryl, Diazepam, Azithromycin, Promethazine, Cyclobenzaprine, Baclofen, Zyprexa, Risperdal, Hydroxyzine

FDA Medwatch Alert: Reumofan Plus: Recall - Undeclared Drug Ingredient

Posted 21 Feb 2013 by Drugs.com

Reumofan Plus USA, LLC and Reumofan USA, LLC is recalling "Reumofan Plus" Tablets, Lot# 99515, exp. 09/16, because they contain undeclared active pharmaceutical ingredients: methocarbamol, dexamethasone, and diclofenac. The recall was initiated after it was discovered that the product was distributed in packaging that did not reveal the presence of the active pharmaceutical ingredients, making it an unapproved drug. One illness has been reported to date in connection with this problem. [UPDATED 8/28/2012] Samantha Lynn Inc. is voluntarily recalling 500 lots of Reumofan Plus Tablets to the consumer level due to findings of undeclared drug ingredients. The FDA sample analysis has found the product to contain methocarbamol and diclofenac. The affected Reumofan Plus lots may include the following lot number(s): 99515 ex096 and expires: 2016. The product is marketed in a green bottle ... Read more

Related support groups: Diclofenac, Voltaren, Methocarbamol, Robaxin, Dexamethasone, Flector, Decadron, Robaxin-750, Zipsor, Cataflam, Cambia, Voltaren-XR, Decadron Tablets, Adrenocot LA, Adrenocot, Cortastat LA, Dexasone LA, Decadron-LA, Primethasone, Dalalone DP

FDA Medwatch Alert: Reumofan Plus Dietary Supplement Relabeled and Sold as “WOW”: Public Warning - Undeclared Drug Ingredients

Posted 21 Dec 2012 by Drugs.com

ISSUE: The U.S. Food and Drug Administration (FDA) is warning the public that the potentially harmful dietary supplement product Reumofan Plus is being relabeled and sold under the name “WOW.”  The product is being marketed to treat arthritis, muscle pain, osteoporosis, bone cancer, and other conditions.  FDA laboratory analysis confirmed that “WOW” contains the same prescription drug ingredients that are in Reumofan Plus, including dexamethasone (a corticosteroid), diclofenac sodium (a non-steroidal anti-inflammatory drug), and methocarbamol (a muscle relaxant).  These ingredients have the potential to cause serious injury. BACKGROUND: FDA warned the public of the harm of Reumofan Plus on June 1, 2012, and again on August 21, 2012.  Since June, FDA has received dozens of adverse event reports, many of them serious, from consumers who used Reumofan Plus.  The reports include liver injury ... Read more

Related support groups: Rheumatoid Arthritis, Osteoarthritis, Muscle Pain, Diclofenac, Voltaren, Methocarbamol, Dietary Supplementation, Robaxin, Dexamethasone, Flector, Decadron, Osteosarcoma, Robaxin-750, Zipsor, Cataflam, Cambia, Voltaren-XR, Decadron Tablets, Adrenocot LA, Adrenocot

FDA Issues New Safety Alert on Reumofan Plus and Reumofan Plus Premium

Posted 21 Aug 2012 by Drugs.com

August 21, 2012 – The U.S. Food and Drug Administration today issued a new warning to consumers about the potential health risks of two products marketed as natural dietary supplements for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions. The products, Reumofan Plus and Reumofan Plus Premium, contain several potentially harmful active pharmaceutical ingredients that are not listed on the product labels. The FDA has received dozens of additional adverse event reports, including death and stroke, associated with the use of Reumofan Plus since the agency issued its first warning about the product on June 1, 2012. Other reports include liver injury, severe bleeding, sudden worsening of glucose (sugar) control, weight gain, swelling, leg cramps and withdrawal syndrome, and adrenal suppression. Consumers who are taking these products or who have recently ... Read more

Related support groups: Diclofenac, Voltaren, Methocarbamol, Robaxin, Dexamethasone, Flector, Decadron, Robaxin-750, Zipsor, Cataflam, Cambia, Voltaren-XR, Decadron Tablets, Adrenocot LA, Adrenocot, Cortastat LA, Dexasone LA, Decadron-LA, Primethasone, Dalalone DP

FDA Medwatch Alert: Reumofan Plus: Recall - Undeclared Drug Ingredient

Posted 2 Jun 2012 by Drugs.com

ISSUE: FDA is warning consumers that Reumofan Plus, marketed as a natural dietary supplement for pain relief and other serious conditions, contains several active pharmaceutical ingredients not listed on the label that could be harmful. An FDA laboratory analysis of Reumofan Plus found that it contains Diclofenac Sodium, a prescription non-steroidal anti-inflammatory drug (NSAID) that may cause increased risk of cardiovascular events such as heart attack and stroke, as well as serious gastrointestinal (GI) adverse events including bleeding, ulceration, and fatal perforation (causing a hole) of the stomach and intestines, and Methocarbamol, a prescription muscle relaxant that can cause sedation, dizziness, low blood pressure, and impair mental or physical abilities to perform tasks such as driving a motor vehicle or operating machinery. The Mexican Ministry of Health discovered that at ... Read more

Related support groups: Pain, Diclofenac, Voltaren, Methocarbamol, Robaxin, Dexamethasone, Flector, Decadron, Robaxin-750, Cataflam, Zipsor, Cambia, Voltaren-XR, Decadron Tablets, Adrenocot LA, Adrenocot, Cortastat LA, Dexasone LA, Decadron-LA, Primethasone

Accidental Medication Poisonings in Kids on the Rise

Posted 16 Sep 2011 by Drugs.com

FRIDAY, Sept. 16 – Despite ongoing prevention efforts, a growing number of young children are being accidentally poisoned with medications, according to new research. The study, which was based on data reported to the American Association of Poison Control Centers between 2001 and 2008, found that medication poisoning among children aged 5 and under increased by 22 percent, although the number of children in the United States in this age group rose by only 8 percent during the study period. "The problem of pediatric poisoning in the U.S. is getting worse, not better," Dr. Randall Bond, of Cincinnati Children's Hospital Medical Center, said in a hospital news release. In conducting the study, which is scheduled for publication in the Journal of Pediatrics, the researchers reviewed information on over 544,000 children who landed in the emergency department due to medication poisoning ... Read more

Related support groups: Suboxone, Xanax, Oxycodone, Methadone, Percocet, Hydrocodone, OxyContin, Vicodin, Klonopin, Lisinopril, Morphine, Norco, Fentanyl, Lortab, Clonazepam, Ambien, Valium, Ativan, Codeine, Opana

Ask a Question

Further Information

Related Condition Support Groups

Opiate Withdrawal, Muscle Spasm, Tetanus

Related Drug Support Groups

Robaxin, Robaxin-750, Carbacot, Skelex

Methocarbamol Patient Information at Drugs.com